Cargando…

Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas

BACKGROUND: The urokinase plasminogen activating system (uPAS) is implicated in neoplastic progression and high tissue levels of uPAS components correlate with a poor prognosis in different human cancers. Despite that, relative few studies are available on the expression and function of the uPAS com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ulisse, Salvatore, Baldini, Enke, Mottolese, Marcella, Sentinelli, Steno, Gargiulo, Patrizia, Valentina, Brancato, Sorrenti, Salvatore, Di Benedetto, Anna, De Antoni, Enrico, D'Armiento, Massimino
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885360/ https://www.ncbi.nlm.nih.gov/pubmed/20403162 http://dx.doi.org/10.1186/1471-2407-10-151

Ejemplares similares

A New Aurora in Anaplastic Thyroid Cancer Therapy
por: Baldini, Enke, et al.
Publicado: (2014)

Iodine Status in Schoolchildren and Pregnant Women of Lazio, a Central Region of Italy
por: Baldini, Enke, et al.
Publicado: (2019)

Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT
por: Baldini, Enke, et al.
Publicado: (2011)

Association of Thyroid Diseases with Primary Extra-Thyroidal Malignancies in Women: Results of a Cross-Sectional Study of 6,386 Patients
por: Prinzi, Natalie, et al.
Publicado: (2015)

In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines
por: Baldini, Enke, et al.
Publicado: (2022)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology?
por: Baldini, Enke, et al.
Publicado: (2013)

Vitiligo and Autoimmune Thyroid Disorders
por: Baldini, Enke, et al.
Publicado: (2017)

Deregulated Expression of Aurora Kinases Is Not a Prognostic Biomarker in Papillary Thyroid Cancer Patients
por: Baldini, Enke, et al.
Publicado: (2015)

Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues
por: Ulisse, Salvatore, et al.
Publicado: (2007)

Relationships of protein biomarkers of the urokinase plasminogen activator system with expression of their cognate genes in primary breast carcinomas
por: Sereff, Seth B., et al.
Publicado: (2019)

PD-1 Ligand Expression in Epithelial Thyroid Cancers: Potential Clinical Implications
por: Ulisse, Salvatore, et al.
Publicado: (2019)

Is Melanoma Progression Affected by Thyroid Diseases?
por: Ulisse, Salvatore, et al.
Publicado: (2022)

Insights on the Association between Thyroid Diseases and Colorectal Cancer
por: Gagliardi, Federica, et al.
Publicado: (2023)

Evaluation of Clinicopathological and Molecular Parameters on Disease Recurrence of Papillary Thyroid Cancer Patient: A Retrospective Observational Study
por: Sorrenti, Salvatore, et al.
Publicado: (2020)

The size criteria in minimally invasive video-assisted thyroidectomy
por: Ruggieri, Massimo, et al.
Publicado: (2007)

The minimally invasive open video-assisted approach in surgical thyroid diseases
por: Ruggieri, Massimo, et al.
Publicado: (2005)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia
por: van Oort, Pouline M., et al.
Publicado: (2019)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

Thyroid Imaging Reporting and Data System Score Combined with the New Italian Classification for Thyroid Cytology Improves the Clinical Management of Indeterminate Nodules
por: Ulisse, Salvatore, et al.
Publicado: (2017)

Iodized Salt May Not Be Sufficient to Guarantee an Adequate Iodine Intake in Pregnant Women
por: Spina, Vincenzo, et al.
Publicado: (2023)

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006)

Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts
por: Chao, Shih-Chun, et al.
Publicado: (2011)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
por: Merino, Paola, et al.
Publicado: (2018)

Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
por: Sugioka, Koji, et al.
Publicado: (2012)

Minimally invasive video-assisted thyroidectomy and transoral video-assisted thyroidectomy: A comparison of two systematic reviews
por: Tartaglia, Francesco, et al.
Publicado: (2020)

The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review
por: Tucker, Torry A., et al.
Publicado: (2021)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Thyroid Diseases and Breast Cancer
por: Baldini, Enke, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same Coin
por: Nemeth, Denise V., et al.
Publicado: (2022)

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_cu39vf2c4rrcu9lqlgm7k6aar5